Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
(CYAD) MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency dated September 08, 2025, indicating that CFIP CLYD (UK) Limited, an affiliate of Fort
Related Questions
What size of stake did CFIP CLYD (UK) Limited acquire in Celyad Oncology, and does it represent a controlling interest?
How might this new shareholder influence Celyad Oncology's strategic direction, pipeline funding, or potential M&A activity?
What short‑term price reaction can be expected from the market upon the disclosure of this transparency notification?